Kusajili – Clinical trials directory

Result of your search per sponsor: Bertrand Arnulf, MD

Woman and Man Max 99 years
Bertrand Arnulf, MD Update Il y a 4 ans

A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma The purpose of the study is to compare the efficacy and safety of masitinib 6 mg/kg/day in combination with bortezomib and dexamethasone to placebo in combination with bortezomib and dexam...

Country France, United States
organs None
Specialty None

unknown

More information